The post-Roe potential of mifepristone and misoprostol in the United States

BMJ Sex Reprod Health. 2024 Dec 30:bmjsrh-2024-202603. doi: 10.1136/bmjsrh-2024-202603. Online ahead of print.

Author

Dana M Johnson¹

Affiliation

¹ Department of Population Health Sciences, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA [email protected].

PMID: 39472043
DOI: 10.1136/bmjsrh-2024-202603

No abstract available

Keywords: Mifepristone; Reproductive Medicine; Reproductive Rights; abortion, induced.

Publication types

Editorial